One of the most notable shifts in the current biopharmaceutical landscape is the move toward serum-free and chemically defined media. Current Cell Therapy Growth Factor Market trends show that researchers are abandoning Fetal Bovine Serum (FBS) in favor of recombinant growth factors to achieve better control over cell environments. This trend is driven by both ethical concerns and the technical...